Schefler, Amy C <br/><br/>
Randomized Trial of Monthly Versus As-Needed Intravitreal Ranibizumab for Radiation Retinopathy-Related Macular Edema: 1-Year Outcomes.  [electronic resource] 

 -  American journal of ophthalmology  08 2020 
 - 165-173 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-1891 
<br/><br/><label>Standard No.: </label>10.1016/j.ajo.2020.03.045  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Angiogenesis Inhibitors--administration & dosage<br/>Combined Modality Therapy<br/>Female<br/>Humans<br/>Intravitreal Injections<br/>Laser Coagulation<br/>Macular Edema--diagnostic imaging<br/>Male<br/>Melanoma--radiotherapy<br/>Middle Aged<br/>Prospective Studies<br/>Radiation Injuries--diagnostic imaging<br/>Radiotherapy--adverse effects<br/>Ranibizumab--administration & dosage<br/>Retina--radiation effects<br/>Tomography, Optical Coherence<br/>Treatment Outcome<br/>Uveal Neoplasms--radiotherapy<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Visual Acuity--physiology<br/>Young Adult<br/>Uveal Melanoma